Emergent BioSolutions, Inc.
| New York Stock Exchange: EBS
Emergent BioSolutions, Inc. is a biopharmaceutical company. It focuses on the research, development, and manufacture of novel vaccines and related products for prophylactic and therapeutic use against common diseases and biological weapons of mass destruction. The company operates through two segments: Biodefense and Biosciences. The Biodefense segment focuses on vaccines and antibody therapies for use against the infectious disease anthrax. The Biosciences segment focuses on protein therapies to treat certain types of cancer and vaccines for use against infectious diseases. The company was founded in May 1998 and is headquartered in Rockville, MD.